Moolec Science (NASDAQ: MLEC)

Industry

Alternative proteins, Cosmetics, Bioprocess equipment, Food ingredients, Seeds & genetics

Topics

Yeast, fermentation & food ingredients, Plant-based meat, dairy & egg, Hybrid seeds & crop breeding

Role

Producer — “…g for scale, and downstream processing to recover mixed plant/animal proteins. - Key products and platforms: -…”

Parent / group

Spinout of Bioceres Crop Solutions

Why it is bioeconomy

Moolec Science is a biotechnology company that uses molecular farming to engineer plants for the production of animal proteins and specialty oils for the food and feed industries.

Not yet cited as a supplier in a graded solution.

Sites 1

• Innovation Centre, Gallows Hill, Warwick, United Kingdom

Production, R&D and other sites from the company's website and automated research; street addresses omitted.

Subsidiaries: Bioceres Group Limited · Gentle Technologies Corp · Nutrecon LLC · Moolec Science Limited · ValoraSoy S.A.

• 2026-09 Latest status: The company is currently facing a winding-up petition filed by Linklaters LLP in the Cayman Islands due to disputed legal fees, while simultaneously undergoing a comprehensive operational and financial restructuring. ↗ ↗ ↗
• Status review: distressed — Nasdaq-listed; winding-up petition in the Cayman Islands (Linklaters, unpaid fees, Jul 2026) still pending; press Sept 2026 describes financial collapse.

Recent news 5

Found by automated search; summaries are machine-written in English. The headline names the company or the summary is about it — check the source before relying on it.

• 2026-10-03 Bioceres CEO faces asset stripping motion from investors el-fondo.com
  Moolec Science is named as a foreign entity that allegedly benefits from asset transfers away from the Argentine Bioceres unit, with accusations that core assets were shifted abroad during a 2025 reorganization. Bioceres says investors had option to swap shares for Moolec equity.
• 2025-09-11 Moolec Science Secures Regulatory Approval for Safflower GLASO Technology in Argentina, Expands U.S. Acreage, and Strengthens Leadership With CFO Appointment accessnewswire.com
  Moolec Science is expanding its biotech portfolio and operations, securing Argentina regulatory approval for safflower GLASO technology, increasing U.S. acreage to boost inventory, integrating Mycofood fungal proteins, and appointing Valeria Falottico as CFO to drive growth and …
• 2025-09-11 Moolec Science Secures Regulatory Approval for Safflower GLASO Technology in Argentina, Expands U.S. Acreage, and Strengthens Leadership With CFO Appointment | … newswire.com
  Moolec Science reports regulatory approval in Argentina for its safflower GLASO technology, expansion of U.S. safflower acreage to boost inventory, and the appointment of Valeria Falottico as CFO, signaling strengthened leadership and scaled commercial potential. The company also …
• 2025-09-11 Moolec Science secures regulatory approval for Safflower GLASO in Argentina | Markets Insider markets.businessinsider.com
  Moolec Science has secured regulatory approval in Argentina for its Safflower GLASO, enabling feed and food use of a gamma-linolenic acid–rich safflower oil and signaling regulatory validation of its molecular farming approach with potential for expanded production and new market …
• 2025-09-11 Moolec Science Secures Regulatory Approval for Safflower GLASO Technology in Argentina, Expands U.S. Acreage, and Strengthens Leadership With CFO Appointment finance.yahoo.com
  Moolec Science is advancing its diversified biotechnologies, securing regulatory approval in Argentina for its safflower GLASO technology, expanding U.S. safflower acreage to boost inventory, and strengthening leadership with a new CFO while integrating its Mycofood fungal …

Ownership & investors 9

Partners & deals 1

Similar companies

Tomorrow Foods · Grupo Bios · ERGO · CJ Brasil · Cipa S.A. · Plena Alimentos · Grupo ADP · BIONOV BIOPRODUTOS

Registry identifiers

• CUIT (Argentina): 30-71786005-1
• Cayman Islands Registrar of Companies: 421988

Sources: cuitonline.com

Funding

• Latest round: Post ipo debt · 2023-10-17 · US$ 21.0 M
• Total raised: US$ 71.0 M

From automated research (company websites, filings, a commercial company index); not checked by hand. Registry identifiers: confirm in the official registry.